| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AAV-mHDM-FH: Safety and expression profile in two murine models of hyper-complement activation
|
Mallett, Grace
|
|
|
230 |
4 |
p.
|
article
|
| 2 |
A CD4+ T cell-intrinsic complement C5aR2-prostacyclin-IL-1R2 axis orchestrates Th1 contraction and is perturbed in Th1-driven disease states
|
Rahman, Jubayer
|
|
|
230 |
4 |
p.
|
article
|
| 3 |
A conserved molecular mechanism orchestrates diverse ligand recognition at the complement anaphylatoxin receptor C3aR
|
Mishra, Sudha
|
|
|
230 |
4 |
p.
|
article
|
| 4 |
A detrimental role for complement C5aR1 activation in Huntington’s disease
|
Marallag, Jianina
|
|
|
230 |
4 |
p.
|
article
|
| 5 |
Advanced assay platform for antibody development: Precision assays for ADCC, ADCP, and CDC
|
Lallemand, Christoffe
|
|
|
230 |
4 |
p.
|
article
|
| 6 |
Advanced glycation end products induce autophagy in endothelial cells through oxidative stress and regulation of the RhoA-mTOR signaling pathway
|
Li, Yan-zhen
|
|
|
230 |
4 |
p.
|
article
|
| 7 |
Age-dependent plasma factor D levels and their clinical implications in complement-mediated kidney diseases
|
Nelson, Angela
|
|
|
230 |
4 |
p.
|
article
|
| 8 |
A multi-omic pipeline identifies complement as a driver of age-dependent progression in a model of multiple sclerosis
|
Champagne-Jorgensen, Kevin
|
|
|
230 |
4 |
p.
|
article
|
| 9 |
Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
|
Wang, Bin
|
|
|
230 |
4 |
p.
|
article
|
| 10 |
Analysis of circulating immune complexes in serum of patients with ANCA-associated glomerulonephritis
|
Oda, Takashi
|
|
|
230 |
4 |
p.
|
article
|
| 11 |
Analysis of human factor H-related gene and protein expression in rheumatoid arthritis synovium identifies a novel mechanism promoting dysregulated complement pathway activation
|
Banda, Nirmal
|
|
|
230 |
4 |
p.
|
article
|
| 12 |
A new screening approach to identify autoantibodies dysregulating the C3bBb convertase in C3 glomerulopathy and immunoglobulin-mediated membranoproliferative glomerulonephritis
|
Roquigny, Julia
|
|
|
230 |
4 |
p.
|
article
|
| 13 |
A novel complement-based drug candidate against fungal infections with promising results in a murine model of invasive pulmonary aspergillosis
|
Harpf, Verena
|
|
|
230 |
4 |
p.
|
article
|
| 14 |
A novel immunoassay platform to study the dynamics of the alternative pathway
|
Gál, Boglár
|
|
|
230 |
4 |
p.
|
article
|
| 15 |
A novel tool for complement activation profiling in AAV gene therapy
|
Kulak, Klaudia
|
|
|
230 |
4 |
p.
|
article
|
| 16 |
Antibodies in the healthy population influence convertase formation
|
Culek, Christopher
|
|
|
230 |
4 |
p.
|
article
|
| 17 |
AON-D21 – Complement C5a-neutralizing human/mouse cross-reactive L-aptamer from bench to phase 2 clinical trial
|
Hoehlig, Kai
|
|
|
230 |
4 |
p.
|
article
|
| 18 |
Assessing C3 nephritic factor function using Luminex-based formation and stabilization assays
|
Fierce, Cecelia
|
|
|
230 |
4 |
p.
|
article
|
| 19 |
A ‘sweet spot’ for complement receptor CD46 activity: CYT-1 regulates glycolytic and moonlighting functions of glycolytic enzymes during human CD4+ T cell activation
|
Kunz, Natalia
|
|
|
230 |
4 |
p.
|
article
|
| 20 |
A versatile screening platform to guide applications for the FH-recruiting peptide 5C6 on non-self surfaces
|
Felsch, Jannes
|
|
|
230 |
4 |
p.
|
article
|
| 21 |
Baseline and longitudinal associations between serum C3/C4 levels, tissue complement biomarkers, and IgA nephropathy in South Asians
|
Alexander, Suceena
|
|
|
230 |
4 |
p.
|
article
|
| 22 |
Beta-cell intrinsic C3 regulates pancreatic islet responses to metabolic stress in vivo
|
Dandavate, Vaishnavi
|
|
|
230 |
4 |
p.
|
article
|
| 23 |
Beyond systemic complement dysregulation: The active contribution of renal cells to complement dysregulation in C3 glomerulopathy
|
Stea, Emma Diletta
|
|
|
230 |
4 |
p.
|
article
|
| 24 |
B lymphocytes impair osteogenesis by inhibiting BMSC differentiation in osteoporosis
|
Peng, Cong
|
|
|
230 |
4 |
p.
|
article
|
| 25 |
Brain-penetrant anti-C7 therapy reduces neurodegeneration and microgliosis in an Alzheimer’s mouse model
|
Reddaway, Jack
|
|
|
230 |
4 |
p.
|
article
|
| 26 |
C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disorders
|
Nicholls, Laura
|
|
|
230 |
4 |
p.
|
article
|
| 27 |
C5aR1 but not C5aR2 signaling promotes fungal clearance in the lung and host survival during systemic infection with Cryptococcus neoformans
|
Wu, Yiquan
|
|
|
230 |
4 |
p.
|
article
|
| 28 |
C5aR2 fuels autoimmune skin disease in murine epidermolysis bullosa acquisita
|
Schanzenbacher, Jovan
|
|
|
230 |
4 |
p.
|
article
|
| 29 |
CD93: A new complement-linked target for immunomodulation and wound healing in SCI
|
Haritopoulou-Sinanidou, Melina
|
|
|
230 |
4 |
p.
|
article
|
| 30 |
CD46 directly engages Sp1 to control gene transcription and HIV expression in human CD4+ T cells
|
Singh, Parul
|
|
|
230 |
4 |
p.
|
article
|
| 31 |
Cell-autonomous complement C3 activity in prostate epithelial cells suppresses malignant transformation through tonic restrain of the MYC-tumorigenesis program
|
Kunz, Natalia
|
|
|
230 |
4 |
p.
|
article
|
| 32 |
Cell-intrinsic complement C3 and FB promote acute kidney injury
|
Grunenwald, Anne
|
|
|
230 |
4 |
p.
|
article
|
| 33 |
Cerebrospinal fluid complement system biomarkers in Alzheimer’s disease
|
Veteleanu, Aurora
|
|
|
230 |
4 |
p.
|
article
|
| 34 |
Characterization and efficacy of a C2-blocking antibody in a rat kidney transplant model
|
Haspeslagh, Eline
|
|
|
230 |
4 |
p.
|
article
|
| 35 |
Characterization of antibody Fc:Fc interactions by a VHH blocking technology
|
van der Meijden, Els
|
|
|
230 |
4 |
p.
|
article
|
| 36 |
Characterization of disease-associated FHR-5 variants for their ligand binding and complement modulating capacity
|
Matola, Alexandra T.
|
|
|
230 |
4 |
p.
|
article
|
| 37 |
Characterization of inherited C3 deficiency – a patient case
|
Humalajoki, Mari
|
|
|
230 |
4 |
p.
|
article
|
| 38 |
Charting the path of dendritic cell subsets in allergic asthma using C5aR1 fate mapping mice
|
Ohms, Mareike
|
|
|
230 |
4 |
p.
|
article
|
| 39 |
C5 inhibition by mAbs: There’s many ways to skin a cat!
|
Cooke, Rebekah S.
|
|
|
230 |
4 |
p.
|
article
|
| 40 |
Clinical significance of serum miR-98-5p in children with Mycoplasma pneumoniae infection complicated with digestive system damage
|
Li, Ying
|
|
|
230 |
4 |
p.
|
article
|
| 41 |
Comparison of complement activation products and eosinophils between bicarbonate-based and lactate-based peritoneal dialysis (PD) solutions in PD patients during introduction periods
|
Suzuki, Masafumi
|
|
|
230 |
4 |
p.
|
article
|
| 42 |
Complement activation and immune responses induced by Nuvaxovid and ChAdOx1 vaccines against Covid-19
|
Nissilae, Eija
|
|
|
230 |
4 |
p.
|
article
|
| 43 |
Complement activation during the early postpartum period in healthy pregnant women
|
Inoue, Norimitsu
|
|
|
230 |
4 |
p.
|
article
|
| 44 |
Complement 5a receptor 2 attenuates diabetic kidney disease by promoting mitochondria-associated endoplasmic reticulum membrane formation mediated by PSS-MFN2 interaction
|
Zhao, Yiyang
|
|
|
230 |
4 |
p.
|
article
|
| 45 |
Complement biomarker responses to factor B and C3 inhibition in C3 glomerulopathy
|
Kruger, Kameron
|
|
|
230 |
4 |
p.
|
article
|
| 46 |
Complement C3 and complement factor H affect glomerular IgA deposition in IgA nephropathy
|
Li, Xianzhi
|
|
|
230 |
4 |
p.
|
article
|
| 47 |
Complement C3a receptor signalling mitigates motor neuron degeneration by modulating neurotoxic astrocytes
|
Julianisya, Alana R.
|
|
|
230 |
4 |
p.
|
article
|
| 48 |
Complement C5aR1 modulates excitatory synaptic transmission in cortical pyramidal neurons via a calcium-independent mechanism
|
Parker, Sandra
|
|
|
230 |
4 |
p.
|
article
|
| 49 |
Complement C3 inhibition mitigates complement activation in clinical platelet concentrates without preventing platelet storage lesions
|
Andersson, Linnea
|
|
|
230 |
4 |
p.
|
article
|
| 50 |
Complement C9-mediated RBC hemolysis drives microvascular obstruction via endothelial necroptosis and hemolyzed RBC aggregation in COVID-19
|
Lun (Mike) Wu, Chia
|
|
|
230 |
4 |
p.
|
article
|
| 51 |
Complement evasion strategies of Candida glabrata clinical isolates and antibody independent binding of C1q to C. glabrata
|
Khan, Tahsin Ahamed
|
|
|
230 |
4 |
p.
|
article
|
| 52 |
Complement expression determines disease severity in mouse models of SARS-CoV-2 and influenza pneumonia
|
Szachowicz, Peter
|
|
|
230 |
4 |
p.
|
article
|
| 53 |
Complement factor I functional assay for assessing CFI variants
|
Goodfellow, Renee
|
|
|
230 |
4 |
p.
|
article
|
| 54 |
Complement is dysregulated in Huntington’s disease in mouse and man
|
Nimmo, Jacqui
|
|
|
230 |
4 |
p.
|
article
|
| 55 |
Complement membrane attack complex alters the proliferation of neural progenitor cells during late embryonic murine neurogenesis
|
Read, Austin
|
|
|
230 |
4 |
p.
|
article
|
| 56 |
Complement regulation in genetically modified pig endothelial cells under xenogeneic and inflammatory conditions
|
Gultom, Mitra
|
|
|
230 |
4 |
p.
|
article
|
| 57 |
Complement signaling as a T-cell checkpoint in the tumor microenvironment
|
Giridharan, Thejaswini
|
|
|
230 |
4 |
p.
|
article
|
| 58 |
Complement therapeutics in neurodegenerative diseases
|
Zelek, Wioleta M.
|
|
|
230 |
4 |
p.
|
article
|
| 59 |
Comprehensive functional analyses of 110 complement factor B variants provide novel diagnostic and structural insights
|
Merinero, Hector Martin
|
|
|
230 |
4 |
p.
|
article
|
| 60 |
Compstatins abolish pathogenic fibroblast function associated with inflammatory maladaptation of tissues
|
Friscic, Jasna
|
|
|
230 |
4 |
p.
|
article
|
| 61 |
Convergent patterns of protein binding promiscuity of complement proteins and immunoglobulins
|
Artero, Mikel Rezola
|
|
|
230 |
4 |
p.
|
article
|
| 62 |
CSL040 ameliorates primary graft dysfunction in pre-clinical models of lung transplantation
|
Tu, Zhenxiao
|
|
|
230 |
4 |
p.
|
article
|
| 63 |
Deciphering the lectin pathway among Systemic Lupus Erythematosus (SLE) patients from Western India
|
Pradhan, Vandana
|
|
|
230 |
4 |
p.
|
article
|
| 64 |
Deep neutrophil phenotyping unveils the impact of complement activation in sickle cell pathophysiology
|
Briones, William
|
|
|
230 |
4 |
p.
|
article
|
| 65 |
Design and development of potent and selective C5aR2 agonists
|
Dent, Joshua
|
|
|
230 |
4 |
p.
|
article
|
| 66 |
Detecting FH–anti-FH immune complexes in MGRS-C3G
|
Jellison, Sydney S.
|
|
|
230 |
4 |
p.
|
article
|
| 67 |
Development and evaluation of alternative pathway Factor B neoantigen assay using novel monoclonal antibodies
|
Stampe, Naia Vad
|
|
|
230 |
4 |
p.
|
article
|
| 68 |
Development of a novel dual fluorescent ELISA (FELISA) for the simultaneous quantification of C3 and C3a in biological fluids
|
Fenn, Gareth D.
|
|
|
230 |
4 |
p.
|
article
|
| 69 |
Development of novel peptide ligands with improved selectivity and pharmacological properties for complement system receptors
|
Clark, Richard
|
|
|
230 |
4 |
p.
|
article
|
| 70 |
Differential complement responses in radiation- vs. chemotherapy-induced senescence
|
Abu-Humaidan, Anas
|
|
|
230 |
4 |
p.
|
article
|
| 71 |
Different patterns of complement activation markers are present in acute and chronic adult primary ITP patients
|
Prohászka, Zoltán
|
|
|
230 |
4 |
p.
|
article
|
| 72 |
Dissecting the role of complement component C3 in the pathogenesis of tuberculosis using in-vivo mouse models
|
Starick, Marick R.
|
|
|
230 |
4 |
p.
|
article
|
| 73 |
Distinct associations of the lectin pathway proteins MASP-2, MASP-3, and MAP-1 with clinical and serological profiles in Systemic Lupus Erythematosus
|
Lindelöf, Linnea
|
|
|
230 |
4 |
p.
|
article
|
| 74 |
Distinct sites of complement activation and regulation in the tumor microenvironment
|
van Keulen, Joanne
|
|
|
230 |
4 |
p.
|
article
|
| 75 |
Divergent effects of early adult microglial versus global C1q deletion on amyloid pathology and synaptic engulfment in an Alzheimer's disease mouse model
|
Petrisko, Tiffany
|
|
|
230 |
4 |
p.
|
article
|
| 76 |
Diversity and hallmarks of metabolites surveyed by MR1
|
Ito, Emi
|
|
|
230 |
4 |
p.
|
article
|
| 77 |
Doxycycline inhibits MMP-9 and inactivates microglia to reduce PNN breakdown and preserve motor neurons in SOD1(G93A) mice
|
Cheung, Sang Won
|
|
|
230 |
4 |
p.
|
article
|
| 78 |
Eculizumab in severe HELLP syndrome – a case report
|
Korkalainen, Noora
|
|
|
230 |
4 |
p.
|
article
|
| 79 |
Effects of cannabinoid receptor-1 antagonist MRI-1867 on C5ar1 signaling in attenuating lung remodeling in mice induced with experimental arthritis
|
Rich, Haydn E.
|
|
|
230 |
4 |
p.
|
article
|
| 80 |
Effects of complement C3/C3b inhibition on control of malignant effusions and neutrophil phenotypes in patients with recurrent epithelial ovarian cancer: Interim analysis of a phase 2 clinical trial
|
Zsiros, Emese
|
|
|
230 |
4 |
p.
|
article
|
| 81 |
Epitope-dependent complement activation and ADCC by anti-NS1 antibodies in targeting infected cells: Implications for dengue vaccine design
|
Thiemmeca, Somchai
|
|
|
230 |
4 |
p.
|
article
|
| 82 |
Evasion of complement and amyloid-beta by the neurotropic pathogen Borrelia burgdorferi in human 3D cultures
|
Heiland, Lilith
|
|
|
230 |
4 |
p.
|
article
|
| 83 |
Exosomes derived from baicalin-pretreated bone marrow mesenchymal stem cells inactivate the TLR4/MyD88/NF-kB pathway to improve asthma
|
Shen, Wenbo
|
|
|
230 |
4 |
p.
|
article
|
| 84 |
Exploring GIPC2 as a key prognostic marker in colorectal cancer linked to enhanced immune response
|
Gu, Jiaoyang
|
|
|
230 |
4 |
p.
|
article
|
| 85 |
Exploring the role of intracellular C3 in activation of the NLRP3 inflammasome in human macrophages
|
Kristensen, Stine
|
|
|
230 |
4 |
p.
|
article
|
| 86 |
Exploring the role of the terminal complement pathway in the DSS-induced colitis model of inflammatory bowel disease
|
Cui, Cedric
|
|
|
230 |
4 |
p.
|
article
|
| 87 |
Exploring the rules for classical complement pathway activation by antibody pairs with co-dependent oligomerization
|
Ovcinnikovs, Vitalijs
|
|
|
230 |
4 |
p.
|
article
|
| 88 |
Factor H-related protein dysregulation and intracellular localizationin osteoarthritis and head & neck cancer
|
Schulz, Daniela
|
|
|
230 |
4 |
p.
|
article
|
| 89 |
Features of circulating factor H immune complexes in complement-mediated diseases
|
Cook, Stephanie
|
|
|
230 |
4 |
p.
|
article
|
| 90 |
FHR2 binds to HUVE necrotic cell and renal glomerular basal membrane, inhibiting TCC deposition and exhibiting cofactor activity
|
Stea, Emma Diletta
|
|
|
230 |
4 |
p.
|
article
|
| 91 |
Ficolin-3 recognizes acylated and carbamylated lysine residues and activates complement in a pH-dependent manner
|
Lindelöf, Linnea
|
|
|
230 |
4 |
p.
|
article
|
| 92 |
GC B cell autonomous complement activation rewires cell metabolism associated with delayed class switching and altered GC dynamics
|
Einwohlt, Philip
|
|
|
230 |
4 |
p.
|
article
|
| 93 |
Genetic C4 deficiency in lower extremity peripheral arterial disease
|
Lokki, A. Inkeri
|
|
|
230 |
4 |
p.
|
article
|
| 94 |
Genetic variants in complement-related genes: potential implications for cancer risk and progression
|
Fung, Jenny N.
|
|
|
230 |
4 |
p.
|
article
|
| 95 |
HDM-FH treatment during static cold storage protects against ischaemic injury in a simulated kidney transplant model
|
Gibson, Beth
|
|
|
230 |
4 |
p.
|
article
|
| 96 |
High-dose radiotherapy modulates the expression and secretion of complement (regulatory) proteins by tumor cells
|
Trottnow, Magnus
|
|
|
230 |
4 |
p.
|
article
|
| 97 |
HMGB1 cleavage by C1s modulates the pro-inflammatory signal induced by TLR2
|
Vigne, Jeanne
|
|
|
230 |
4 |
p.
|
article
|
| 98 |
Host cell origin drives divergent complement neutralization mechanisms of Chandipura virus
|
Johnson, John
|
|
|
230 |
4 |
p.
|
article
|
| 99 |
Hypothalamic C3aR activation by astrocyte-derived complement C3a drives obesity and cardiometabolic dysfunction
|
Gragoll, Carolin
|
|
|
230 |
4 |
p.
|
article
|
| 100 |
Immunophenotypic characteristics of Langhans giant cells and the role of CCR7 in their formation
|
Jiang, Yumeng
|
|
|
230 |
4 |
p.
|
article
|
| 101 |
Impact of the A09/A15 epitope on structural assembly and function of C1q in the light of Systemic Lupus Erythematosus
|
Klehr, Juliane
|
|
|
230 |
4 |
p.
|
article
|
| 102 |
Infection risk in pediatric complement inhibition: Insights from a single-center experience
|
Graciaa, Sara
|
|
|
230 |
4 |
p.
|
article
|
| 103 |
Inflammatory cytokines drive local C3 transcription to regulate metabolic reprogramming in kidney epithelial cells and subsequent fibrosis
|
Freiwald, Tilo
|
|
|
230 |
4 |
p.
|
article
|
| 104 |
Inhibition of the complement component C5 and the Toll-like receptor molecule CD14 prevents systemic and local kidney inflammation in mice experiencing brain death.
|
Mollnes, Tom Eirik
|
|
|
230 |
4 |
p.
|
article
|
| 105 |
Insights into potentiation of Factor H function by the Pneumococcal surface protein C (PspC): the structure of Factor H domains 8-14 in complex with PspC
|
Sichau, Jannik
|
|
|
230 |
4 |
p.
|
article
|
| 106 |
Integrated transcriptomic, metabolomic, and lipidomic analyses reveal a unique lipid profile of regulatory T cells upon activation
|
Sato, Yohei
|
|
|
230 |
4 |
p.
|
article
|
| 107 |
Integration of structural modeling and CADD scores improve variant classification for CFH SCRs 5-18
|
Donelson, Cobey
|
|
|
230 |
4 |
p.
|
article
|
| 108 |
Intracellular C1r impacts tumor progression and immune microenvironment in renal cancer
|
Merle, Nicolas
|
|
|
230 |
4 |
p.
|
article
|
| 109 |
Investigating complement receptor C3aR1 signalling in metabolic dysfunction in the R6/1 mouse model of Huntington’s disease
|
Lerskiatiphanich, Titaya
|
|
|
230 |
4 |
p.
|
article
|
| 110 |
Investigating the role of neuronally-expressed C5aR1 in motor neuron disease
|
Risby-Jones, Grace
|
|
|
230 |
4 |
p.
|
article
|
| 111 |
Isoform-specific detection and quantification of complement C4A via novel mAbs
|
Holm, Bettina Eide
|
|
|
230 |
4 |
p.
|
article
|
| 112 |
Kasumi-1 exosome plays a major T-cell immune evasion role in TP53-type acute leukemia
|
Du, Yunyun
|
|
|
230 |
4 |
p.
|
article
|
| 113 |
LINC00461 promotes macrophage M1 polarization by inhibiting KLF4 transcription
|
Gao, Bicong
|
|
|
230 |
4 |
p.
|
article
|
| 114 |
Live-cell single-molecule imaging of a new fluorescent C5a receptor antagonist reveals the heterogeneous spatiotemporal dynamics of C5aR1 at the plasma membrane
|
Sun, Jinda
|
|
|
230 |
4 |
p.
|
article
|
| 115 |
Liyan Kaiyin Formula relieves reflux pharyngitis by regulating M1 macrophage polarization via the NF-κB/NLRP3 pathway
|
Wang, Lirong
|
|
|
230 |
4 |
p.
|
article
|
| 116 |
Low peripheral blood B lymphocyte count predicts poor outcome in patients with multiple myeloma
|
Wang, Yuqi
|
|
|
230 |
4 |
p.
|
article
|
| 117 |
Macrophage-derived complement factor H restrains kidney inflammation and fibrosis in immune complex-mediated disease
|
Alexander, Jessy
|
|
|
230 |
4 |
p.
|
article
|
| 118 |
Major outer membrane protein P5 of non-typeable Haemophilus influenzae interacts with human vitronectin and contributes to serum resistance
|
Jonsson, Sandra
|
|
|
230 |
4 |
p.
|
article
|
| 119 |
Mapping inhibitory epitopes on C7 with monoclonal antibodies
|
MacIntosh-Smith, William
|
|
|
230 |
4 |
p.
|
article
|
| 120 |
Mechanism of action of bi-specific antibodies recruiting endogenous complement inhibitors for targeted local complement inhibition in the context of rheumatoid arthritis
|
Trouw, Leendert
|
|
|
230 |
4 |
p.
|
article
|
| 121 |
Metabolic changes in the retinal pigment epithelium of patients with complement factor H haploinsufficiency
|
Lim, Rayne
|
|
|
230 |
4 |
p.
|
article
|
| 122 |
Mice lacking MASP-1 and/or MASP-3 are protected from the development of retinal degeneration in a murine model of NaIO3-induced dry age-related macular degeneration (AMD)
|
Machida, Takeshi
|
|
|
230 |
4 |
p.
|
article
|
| 123 |
Microglial Complement C5aR1 signalling drives inflammasome mediated neuropathology in Parkinson’s disease
|
Albornoz, Eduardo
|
|
|
230 |
4 |
p.
|
article
|
| 124 |
MicroRNA sequencing of plasma exosomes reveals complement dysregulation in COVID-19
|
Shadid, Anthony
|
|
|
230 |
4 |
p.
|
article
|
| 125 |
Mitochondrial RNA/RIG-I promotes Caspase-1/GSDMD-mediated inflammation in sepsis-associated acute kidney injury
|
Jiao, Jie
|
|
|
230 |
4 |
p.
|
article
|
| 126 |
Modulation of complement-mediated inflammation in the mdx mouse model of duchenne muscular dystrophy by PK007
|
Yarlagadda, Sai
|
|
|
230 |
4 |
p.
|
article
|
| 127 |
Modulation of cytokine expression by E. coli Nissle 1917 and its OMV in intestinal epithelial cell line HT-29
|
Hamidzadeh, Seyed Amir Hossein
|
|
|
230 |
4 |
p.
|
article
|
| 128 |
Molecular basis of naturally-encoded signaling-bias at the complement anaphylatoxin receptor, C5aR1
|
Dalal, Annu
|
|
|
230 |
4 |
p.
|
article
|
| 129 |
Molecular epidemiology and comparative virulence patterns of Acinetobacter baumannii isolates from war-related injuries in Ukraine
|
Boral, Jale
|
|
|
230 |
4 |
p.
|
article
|
| 130 |
Moss-produced complement factor H (CPV-104) as a therapeutic regulator in complement-mediated diseases
|
Dabrowska-Schlepp, Paulina
|
|
|
230 |
4 |
p.
|
article
|
| 131 |
Motor neuron disease C9orf72 dipeptides mediate neurotoxicity in human brain organoids through activation of C5aR1
|
Cao, Yuzhihan
|
|
|
230 |
4 |
p.
|
article
|
| 132 |
Mucosal complement Factor B production by intestinal epithelium is required in homeostasis and response to injury
|
Kulkarni, Devesha
|
|
|
230 |
4 |
p.
|
article
|
| 133 |
Neutrophil plasticity in epidermolysis bullosa acquisita: Bridging innate and adaptive immunity via C5aR2 signaling
|
Niese, Dennis
|
|
|
230 |
4 |
p.
|
article
|
| 134 |
New roles of intracellular C3 in triggering immune responses
|
Kuska, Katarzyna
|
|
|
230 |
4 |
p.
|
article
|
| 135 |
Novel antibodies and assays to ascertain the role of C4 protein variants in Schizophrenia risk
|
Baillie, Kirsten L.
|
|
|
230 |
4 |
p.
|
article
|
| 136 |
Novel anti-clusterin monoclonals as tools for characterising clusterin expression in biofluids and tissues
|
Byrne, Robert A.J.
|
|
|
230 |
4 |
p.
|
article
|
| 137 |
Novel functions of CD59 isoforms IRIS-1 and IRIS-2 in insulin-producing pancreatic β-cells
|
Tran, Thu-Ha
|
|
|
230 |
4 |
p.
|
article
|
| 138 |
Novel metabolic role of the complement activator MASP-2 in regulating pancreatic β-cell function
|
Sridharan, Gautham
|
|
|
230 |
4 |
p.
|
article
|
| 139 |
Novel quantitative ELISA reveals dynamics of pro-Factor D conversion during alternative complement pathway activation
|
Plchová, Tereza Alica
|
|
|
230 |
4 |
p.
|
article
|
| 140 |
Opposing effects of animal models of type 1 and type 2 diabetes on factor D expression and systemic alternative pathway activity
|
Colineau, Lucie
|
|
|
230 |
4 |
p.
|
article
|
| 141 |
Peptide-mediated modulation of T cell-expressed complement-like CD109boosts T cell anti-tumor responses
|
Merle, Nicolas
|
|
|
230 |
4 |
p.
|
article
|
| 142 |
Phellodendrine chloride alleviates gouty arthritis through IL-6/STAT3 signaling pathway
|
Qin, Yu-yao
|
|
|
230 |
4 |
p.
|
article
|
| 143 |
Pre-clinical characterization of CSL040, a soluble complement receptor 1 (CR1) fragment
|
Wymann, Sandra
|
|
|
230 |
4 |
p.
|
article
|
| 144 |
Pregnancy complications in C5aR2-deficient mice are caused by an altered uterine immune cell network
|
Kähler, Katja
|
|
|
230 |
4 |
p.
|
article
|
| 145 |
Profiling complement dysregulation in frontotemporal dementia using cerebrospinal fluid, plasma, and exosomes
|
Watkins, Lewis M.
|
|
|
230 |
4 |
p.
|
article
|
| 146 |
Quantification and clustering of immune states in hepatitis B Cirrhosis
|
Hou, Wei
|
|
|
230 |
4 |
p.
|
article
|
| 147 |
Rapid complement inhibition with the C5 inhibitor crovalimab: Timing analysis using animal model and composer trial data
|
Dixon, Bradley P.
|
|
|
230 |
4 |
p.
|
article
|
| 148 |
Reconstitution of a fully functional recombinant membrane attack complex for molecular biology studies
|
Ho, Bill
|
|
|
230 |
4 |
p.
|
article
|
| 149 |
Regulation instead of inhibition: a triple fusion protein of complement regulators (TriFu) is superior in protecting animals in a rat xenotransfusion model when compared to C5-inhibition
|
Savukoski, Susa
|
|
|
230 |
4 |
p.
|
article
|
| 150 |
Renal pathology as a predictor of complement dysregulation in C3 glomerulopathy
|
Hall, Jillian
|
|
|
230 |
4 |
p.
|
article
|
| 151 |
Role of complement components 3A (C3A) and 5A (C5A) in the acute-to-chronic pain transition in a mouse model of neuropathic pain
|
Vygonskaya, Marina
|
|
|
230 |
4 |
p.
|
article
|
| 152 |
Senescent erythrocytes as a trigger of complement activation and implications for breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria patients
|
Erdemci-Evin, Sümeyye
|
|
|
230 |
4 |
p.
|
article
|
| 153 |
Serum LINC01278 serves as a negative biomarker for sepsis and its up-regulation inhibits LPS-induced inflammatory response in THP-1 cells
|
Gu, Ying
|
|
|
230 |
4 |
p.
|
article
|
| 154 |
Single-cell transcriptomic changes in mouse hearts during collagen-induced arthritic inflammation
|
Hok, Kathryn
|
|
|
230 |
4 |
p.
|
article
|
| 155 |
Something about the at least 50 different complexes of the initiating molecules of the lectin pathway and the polyreactivity of the pattern recognition molecules
|
Thiel, Steffen
|
|
|
230 |
4 |
p.
|
article
|
| 156 |
Spatial transcriptomics maps complement-driven cell-to-cell interactions during acute kidney injury
|
Sabapathy, Vikram
|
|
|
230 |
4 |
p.
|
article
|
| 157 |
Structural basis of complement C3 recognition by both convertases
|
Jia, Changhao
|
|
|
230 |
4 |
p.
|
article
|
| 158 |
Structural insights into how the membrane attack complex is recognised by the diagnostic antibody aE11
|
Ho, Bill
|
|
|
230 |
4 |
p.
|
article
|
| 159 |
Targeted binding and activation of native C3 without proteolytic cleavage induced by flip/flopped cell membranes
|
Eikrem, David
|
|
|
230 |
4 |
p.
|
article
|
| 160 |
Targeted treatment with pegcetacoplan for adolescents with C3G or primary (idiopathic) IC-MPGN in the VALIANT phase 3 trial
|
Vivarelli, Marina
|
|
|
230 |
4 |
p.
|
article
|
| 161 |
Targeting C5a/C5aR1-mediated NETosis restores immunotherapy response in STK11-mutant lung cancer
|
Daniel, Ajona
|
|
|
230 |
4 |
p.
|
article
|
| 162 |
Targeting C5a inflammation in ALS: Ex vivo findings from PMX205 phase Ib trial
|
Fung, Jenny
|
|
|
230 |
4 |
p.
|
article
|
| 163 |
Targeting complement anaphylatoxin C3a receptor to break immunotherapy resistance in colorectal cancer
|
St. Thomas, Nadia
|
|
|
230 |
4 |
p.
|
article
|
| 164 |
The Alzheimer’s disease-associated complement receptor 1 variant CR1*2 enhances glial phagocytosis of relevant targets and impacts neuroinflammation
|
Daskoulidou, Nikoleta
|
|
|
230 |
4 |
p.
|
article
|
| 165 |
The C3-C3aR axis modulates trained immunity in alveolar macrophages
|
Earhart, Alexander
|
|
|
230 |
4 |
p.
|
article
|
| 166 |
The complement C3a receptor regulates the tumour microenvironment
|
Rolfe, Barbara
|
|
|
230 |
4 |
p.
|
article
|
| 167 |
The complement system is activated and regulated differently during infection with the orthoflaviviruses, dengue and zika virus
|
Carr, Jill
|
|
|
230 |
4 |
p.
|
article
|
| 168 |
The conversion of native C3 to C3(H2O) is contact-driven facilitated by neutrophil extracellular traps
|
Sahu, Sanjaya Kumar
|
|
|
230 |
4 |
p.
|
article
|
| 169 |
The enigmatic role of C5aR2 in diabetic kidney disease
|
Trambas, Inez
|
|
|
230 |
4 |
p.
|
article
|
| 170 |
The evaluation of clinical scoring system in complement mediated-TMA patients
|
Tan, Meng
|
|
|
230 |
4 |
p.
|
article
|
| 171 |
The Fc fragment of soluble IgMs binds C1q to activate the first step of the classical complement pathway, while inhibiting complement-dependent cytotoxicity
|
Pinto, Andrea J.
|
|
|
230 |
4 |
p.
|
article
|
| 172 |
The four functional segments of Factor H: Role in physiological target recognition and contribution to disease
|
Zipfel, Peter
|
|
|
230 |
4 |
p.
|
article
|
| 173 |
The human complement factor H-related protein FHR-2 enhances complement activation on host and bacterial ligands
|
Schneider, Andrea E.
|
|
|
230 |
4 |
p.
|
article
|
| 174 |
The power of fusion: Tuning pharmacokinetic and pharmacodynamic properties of complement-modulating peptides and proteins via antibody engineering
|
Meyer, Florian
|
|
|
230 |
4 |
p.
|
article
|
| 175 |
The role of C3 in steatotic liver disease
|
Iliescu, Adrian
|
|
|
230 |
4 |
p.
|
article
|
| 176 |
The role of intracellular and cell-autonomous C3 in NF-κB priming in human macrophages
|
Årseth, Charlotte
|
|
|
230 |
4 |
p.
|
article
|
| 177 |
The toxin CyaA from Bordetella pertussis as a potential modulator of Complement receptor 3 (CR3) function
|
Jachmann, Marie
|
|
|
230 |
4 |
p.
|
article
|
| 178 |
The tumor- and apoptosis-associated annexin A2 is a new ligand for FHL-1 and Factor H-related proteins – annexin-bound FHR-5 enhances alternative pathway activation
|
Szakács, Dávid
|
|
|
230 |
4 |
p.
|
article
|
| 179 |
The vector-pathogen anti-complement evolution dictates host skin immunomodulation for multimodal Lyme disease bacterial transmission
|
Fernandes, Carly
|
|
|
230 |
4 |
p.
|
article
|
| 180 |
Three cryo-EM structures of the complement C3d-complement receptor 3 complex reveal a novel layer of dynamics and the signaling mechanism underlying iC3b dependent phagocytosis
|
Andersen, Gregers
|
|
|
230 |
4 |
p.
|
article
|
| 181 |
Transcriptional cross-talk regulates complement C3 expression during CD4+ T-cell activation
|
Trujillo-Ochoa, Jorge-Luis
|
|
|
230 |
4 |
p.
|
article
|
| 182 |
Tumor-derived factor B drives tumor growth and anti-PD-1 resistance in STK11-mutant lung adenocarcinoma
|
Suzuki, Sora
|
|
|
230 |
4 |
p.
|
article
|
| 183 |
Untargeted metabolomics reveals postoperative metabolic dynamics in hepatic cystic echinococcosis patients
|
Tuerxun, Kahaer
|
|
|
230 |
4 |
p.
|
article
|
| 184 |
Update on protein array screening of the ficolin-3 interactome
|
Ebert, Roland
|
|
|
230 |
4 |
p.
|
article
|
| 185 |
Utilising induced pluripotent stem cells (iPSCs) to model the outer retina for complement gene therapy delivery
|
Hammadi, Sarah
|
|
|
230 |
4 |
p.
|
article
|
| 186 |
VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN
|
Nester, Carla M.
|
|
|
230 |
4 |
p.
|
article
|
Journal description